top of page

Drug Discovery & Development

Prescription Medication

Next-Generation Sequencing (NGS) significantly accelerates drug discovery and development by providing comprehensive insights into the genetic determinants of diseases. It enables the identification of novel targets by revealing mutations, gene expressions, and complex biomarkers associated with various conditions. This detailed genomic understanding helps in designing targeted therapies that are more effective and have fewer side effects. Furthermore, NGS facilitates patient stratification in clinical trials, ensuring that treatments are tested on populations most likely to benefit, thereby increasing the efficiency of trials and the speed at which new drugs can be brought to market. Overall, NGS empowers the development of personalized medicine, allowing for treatments that are tailored to the genetic makeup of individual patients, enhancing therapeutic outcomes and reducing the burden of adverse reactions.

Related NGS Solutions

  • Whole Transcriptome Sequencing

  • Target Region Sequencing

  • Chromatin Immunoprecipitation Sequencing (ChIP-seq)

  • Whole Genome Bisulfite Sequencing (WGBS)

  • Reduced-Representation Bisulfite Sequencing (RRBS)

  • RNA Immunoprecipitation Sequencing (RIP-seq)

  • Clinical Whole Exome Sequencing

More Applications

bottom of page